Sarvada Pharma

Forxiga 10mg tablets (dapagliflozin) are primarily used to treat Type 2 diabetes mellitus by helping to lower blood sugar levels, reducing the risk of cardiovascular disease, heart failure, and slowing the progression of chronic kidney disease. It works by prompting the kidneys to remove excess glucose through urine. 

Forxiga (dapagliflozin) is an SGLT2 inhibitor used alongside diet and exercise to manage type 2 diabetes by helping the kidneys remove excess sugar through urine. It is also used to reduce the risk of hospitalization for heart failure and manage chronic kidney disease. 

Novonorm 2mg tablets (containing Repaglinide) are oral anti-diabetic medication used to manage Type 2 Diabetes mellitus in adults, primarily to control blood sugar levels after meals. It works by stimulating the pancreas to release more insulin. It is typically taken before meals to prevent high blood sugar. 

Mounjaro (tirzepatide) KwikPen is a once-weekly, pre-filled, single-dose injection used to improve blood sugar control in adults with type 2 diabetes and for chronic weight management. It acts as a GIP and GLP-1 receptor agonist to regulate insulin and reduce appetite. It is injected subcutaneously into the abdomen, thigh, or upper arm. 

Mounjaro (tirzepatide) 15mg KwikPen is a high-strength, once-weekly subcutaneous injection used to improve blood sugar control in adults with type 2 diabetes and for chronic weight management. It acts as a GIP and GLP-1 receptor agonist, reducing hunger and promoting fullness. This prescription medication is typically reserved for patients needing maximum glycemic control. 

Mounjaro (tirzepatide) 7.5mg KwikPen is a once-weekly, self-administered subcutaneous injection used to improve blood sugar control in Type 2 diabetes and aid weight management. It works by activating GIP and GLP-1 receptors to increase insulin, slow gastric emptying, and reduce appetite. It is typically prescribed after initial 2.5mg and 5mg doses, as part of a lifestyle plan. 

Invokana (canagliflozin) is an oral medication used alongside diet and exercise to treat Type 2 diabetes in adults. It lowers high blood sugar, reduces the risk of major cardiovascular events (heart attack, stroke, or death) in patients with heart disease, and helps manage kidney function. It acts as an SGLT2 inhibitor, causing kidneys to remove excess sugar via urine. 

Amaryl (glimepiride) tablets are indicated to lower blood sugar levels in adults with type 2 diabetes when diet, exercise, and weight reduction are insufficient to control hyperglycemia. As a sulfonylurea, this medication works by increasing the amount of insulin produced by the pancreas. 

25mg Jardiance (empagliflozin) tablets are used to improve glycemic control in adults with type 2 diabetes, reduce cardiovascular death risk in patients with cardiovascular disease, and treat heart failure or chronic kidney disease to reduce hospitalization. It works by inhibiting the SGLT2 protein in the kidneys to remove excess blood sugar through urine. 

Imeglyn 500mg tablets (Imeglimin Hydrochloride) are a prescription oral medication used to manage blood sugar levels in adults with Type 2 Diabetes Mellitus, often when diet and exercise alone are insufficient. It acts as a dual-mechanism agent that increases insulin secretion, enhances insulin sensitivity in muscles/liver, and protects beta-cell function. 

Victoza (6mg/mL Liraglutide) is a prescription injectable medication used alongside diet and exercise to improve blood sugar control in adults and children (10+ years) with type 2 diabetes. It is a once-daily subcutaneous injection that mimics the GLP-1 hormone to help manage glucose levels. 

Rybelsus (semaglutide) 14 mg tablets are a daily oral medication approved to improve blood sugar control in adults with type 2 diabetes, usually taken with diet and exercise. It acts as a GLP-1 receptor agonist, reducing blood sugar by increasing insulin, lowering glucagon, and slowing stomach emptying.